Evidence map›Paper›PMID 27114693›Full record

ArticlePharmacognosy research2016

Kolaviron, Biflavonoid Complex from the Seed of Garcinia kola Attenuated Angiotensin II- and Lypopolysaccharide-induced Vascular Smooth Muscle Cell Proliferation and Nitric Oxide Production.

Ademola Adetokunbo Oyagbemi, Temidayo Olutayo Omobowale, Adeolu Alex Adedapo, Momoh Audu Yakubu

Open access · hybridAbstract read
In one paragraph

Article in Pharmacognosy research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Biological Evaluation ofAdvances in pharmacological and pharmaceutical sciences · 2022
    Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Ademola Adetokunbo OyagbemiDepartment of Veterinary Physiology, Biochemistry and Pharmacology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
Temidayo Olutayo OmobowaleDepartment of Veterinary Physiology, Biochemistry and Pharmacology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
Adeolu Alex AdedapoDepartment of Veterinary Physiology, Biochemistry and Pharmacology, Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria.
Momoh Audu YakubuDepartment of Environmental and Interdisciplinary Sciences, College of Science, Engineering, and Technology, Texas Southern University, Houston, TX 77004, USA; Vascular Biology Unit, Center for Cardiovascular Diseases, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA.
Department of Physics, Mathematics and Informatics · BYUniversity of Ibadan · NG

Funding

TISSUE CULTURE FACILITY DVMT FOR HYPERTENSION, DIABETES, TOXICOLOGY &AIDS RESG12RR003045 · NCRR · TEXAS SOUTHERN UNIVERSITY · PI HAYES, BARBARA ELAINE · 1986 to 2011
$13.6M
TEXAS SOUTHERN UNIVERSITY RESEARCH SCIENTIST AWARDUH1HL003674 · NHLBI · TEXAS SOUTHERN UNIVERSITY · PI OYEKAN, ADEBAYO O. · 1996 to 2004
$2.5M
TEXAS SOUTHERN UNIVERSITY RESEARCH SCIENTIST AWARDR25HL003674 · NHLBI · TEXAS SOUTHERN UNIVERSITY · PI OYEKAN, ADEBAYO O. · 2006 to 2010
$2.0M
Cerebral Microvascular Endothelin ProductionR15HL070669 · NHLBI · TEXAS SOUTHERN UNIVERSITY · PI YAKUBU, MOMOH A · 2002 to 2003
$182k
ADDITION AND RENOVATION TO GRAY HALLC06RR012537 · NCRR · TEXAS SOUTHERN UNIVERSITY · PI HAYES, BARBARA ELAINE · 1997 to 1997
–
NCRR NIH HHS C06 RR012537NCRR NIH HHS G12 RR003045NHLBI NIH HHS R15 HL070669NHLBI NIH HHS R25 HL003674NHLBI NIH HHS UH1 HL003674
6 · The paper itself

Abstract

introductionKolaviron (KV), a biflavonoid extract from Garcinia kola seeds has been reported to possess anti-inflammatory, anti-oxidant, hepato-protective, cardio-protective, nephro-protective and other arrays of chemopreventive capabilities but the mechanism of action is still not completely understood. MATERIALS AND

methodsIn this study, we investigated the anti-proliferative, anti-inflammatory and anti-oxidative potential of KV in cultured Vascular Smooth Muscle Cells (VSMCs). Effects of KV (25-100 μg/mL) on VSMC proliferation alone or following treatments with mitogen and proinflammatory agents Angiotensin II (Ag II, 10(-6) M) and lipopolysaccharide (LPS, 100 μg/mL) and effects on NO production were determined. Cellular proliferations were determined by MTT assay, nitric oxide (NO) level was determined by Griess assay. KV dose-and time dependently attenuated VSMC growth.

resultsTreatment of VSMCs with Ag II and LPS significantly enhanced proliferation of the cell which was significantly attenuated by the treatment with KV. Treatment of VSMC with LPS significantly increased nitric oxide (NO) level in the media which was attenuated by KV. These results demonstrated anti-proliferative anti-inflammatory properties of KV as it clearly inhibited cellular proliferation induced by mitogens as well as LPS-induced inflammatory processes.

conclusionTherefore, KV may mitigate cardiovascular conditions that involve cell proliferation, free radical generation and inflammatory processes such as hypertension, diabetes and stroke. However, the molecular mechanism of action of KV needs to be investigated. SUMMARY: Angiotensin-induced cell proliferationKolaviron mitigates angiotensin-induced cell proliferationKolaviron ameliorates nitric oxide productionKolaviron offers antioxidant activity. Abbreviations Used: VSMCs: Vascular Smooth Muscle Cells, Ag II: Angiotensin II, KV: Kolaviron, LPS: lypopolysaccharide, NO: Nitric Oxide, DMEM: Dulbecco's modified Eagle's medium, MTT: (3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide), DMSO: Dimethylsulfoxide, GB1: Garcinia kola biflavonoid-1, GB2: Garcinia kola biflavonoid-2, ROS: Reactive oxygen species, ET-1: Endothelin-1, NF-κB: Nuclear factor-kappa beta, COX-2: Cyclooxygenase-2.

Indexed as

Angiotensin IIcardiovascular diseasescell proliferationkolavironlipopolysaccharidenitric oxidevascular smooth muscle cells

Identifiers

PMID27114693
PMCPMC4821108
OpenAlexW2297413540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.